[ORGANIZATION]
Biogen Inc.
Featured in 2 tracked stories · first seen
Situations
US biotech Q2 earnings reports
2 clusters · 12 sources · last updated
Latest: Amgen posts 9% Q2 sales growth and earnings beat as biotech peers report results
In late July 2026 Biogen posted a modest 3% year‑over‑year revenue rise to $2.7 billion, driven by its multiple‑sclerosis drugs and newer products such as Skyclarys and Leqembi. A week later Amgen reported stronger Q2 pe
Q2 2026 corporate earnings announcements
2 clusters · 7 sources · last updated
Latest: Biogen posts Q2 2026 revenue rise, shares jump 1.8%
In late July 2026, a series of Q2 earnings releases from banks and tech‑focused firms highlighted profit recovery. Columbia Banking System reported EPS $0.73, a 3.93% net interest margin and a loan portfolio of $47.2 bn